RTI Biologics, Inc. (NASDAQ:RTIX)

CAPS Rating: 5 out of 5

The Company uses natural tissues and innovative technologies to produce orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes.

Recs

0
Player Avatar Subida (< 20) Submitted: 3/2/2010 9:42:25 PM : Outperform Start Price: $4.00 RTIX Score: -28.02

Still attractive even after the recent run-up. Trends are Friends, folks. There may be a slight retracement, but RTI is going up. Expect $5.00 by the end of the year. This is a profitable Biotech/Med Device company that is trading like a spec stock. PEG under 0.5, low debt.

^Subida

Featured Broker Partners


Advertisement